Dow Jones Industrial Average
) is trading down 170.0 points (-1.4%) at 12,332 as of Wednesday, May 23, 2012, 10:35 a.m. ET. During this time, 185.5 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 731.4 million. The NYSE advances/declines ratio sits at 531 issues advancing vs. 2,349 declining with 99 unchanged.
Thursday, May 24, 2012 is the ex-dividend date for Dow component
). Owners of shares as of market close today will be eligible for a dividend of 61 cents per share. At a price of $63.30 as of 10:35 a.m. ET, the dividend yield is 3.8% compared to the average Dow component yield of 2.9%.
The average volume for Johnson & Johnson has been 11.2 million shares per day over the past 30 days. Johnson & Johnson has a market cap of $174.31 billion and is part of the
industry. Shares are down 3.1% year to date as of Tuesday's close.
Johnson & Johnson engages in the research, development, manufacture, and sale of various products in the health care field worldwide. The company has a P/E ratio of 17.4, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 17.7.
- Practice your dividend trading strategies and win cash in our stock game.
TheStreet Ratings rates Johnson & Johnson as a
. The company's strengths can be seen in multiple areas, such as its increase in net income, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, growth in earnings per share and expanding profit margins. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity.
- You can view the full Johnson & Johnson Ratings Report.